RNA (STOCKS)
Atrium Therapeutics, Inc. Common Stock
$12.750000
+0.380000 (+3.07%)
Prev close: $12.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kathleen Gallagher
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $218.27M
- Employees
- 391
- P/E (TTM)
- —
- P/B (TTM)
- 0.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.97 | $-1.06 | +0.0905 | +8.53% |
Financial Statements
| Assets | $292.36M |
| Current Assets | $285.57M |
| Prepaid Expenses | $2.58M |
| Other Current Assets | $282.99M |
| Noncurrent Assets | $6.80M |
| Fixed Assets | $4.34M |
| Other Non-current Assets | $2.46M |
| Liabilities | $58.26M |
| Current Liabilities | $21.91M |
| Accounts Payable | $807.00K |
| Other Current Liabilities | $21.10M |
| Noncurrent Liabilities | $36.35M |
| Equity | $234.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $234.10M |
| Liabilities And Equity | $292.36M |